Showing results (311-320 of 373) with videos related to
Sort By:
Pageof 38
Journal of Immunology (Baltimore, Md. : 1950)|April 15, 1996
Analysis of MHC class II presentation of particulate antigens of B lymphocytesL Vidard, M Kovacsovics-Bankowski, S K Kraeft, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 15, 1986
Anti-idiotypic treatment of BALB/c mice induces CRIa-bearing suppressor cells with altered Igh-restricted functionM Slaoui, J Urbain, A Lowy, et al.Archives of Disease in Childhood|October 1, 1988
Echocardiographic diagnosis of fetal heart defects in mid trimesterI A Parness, S B Yeager, S P Sanders, et al.Proceedings of the National Academy of Sciences of the United States of America|January 1, 1992
Murine B7 antigen provides an efficient costimulatory signal for activation of murine T lymphocytes via the T-cell receptor/CD3 complexH Reiser, G J Freeman, Z Razi-Wolf, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1982
Antigen-specific suppression of cytotoxic T cell responses: an idiotype-bearing factor regulates the cytotoxic T cell response to azobenzenearsonate-coupled cellsM I Greene, S Ratnofsky, M Takaoki, et al.The Journal of Investigative Dermatology|July 1, 1994
Trinitrophenol reactive T-cell hybridomas recognize antigens that require antigen processingJ Ma, J H Wang, M S Sy, et al.Cell|November 7, 1986
Structural characterization of the TAP molecule: a phosphatidylinositol-linked glycoprotein distinct from the T cell receptor/T3 complex and Thy-1H Reiser, H Oettgen, E T Yeh, et al.The Journal of Experimental Medicine|October 1, 1979
Hapten-specific T-cell responses to 4-hydroxy-3-nitrophenyl acetyl. II. Demonstration of idiotypic determinants on suppressor T cellsJ Z Weinberger, R N Germain, S T Ju, et al.Obstetrics and Gynecology|December 1, 1990
Early amniocentesis: report of 407 cases with neonatal follow-upC A Penso, M M Sandstrom, M F Garber, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1993
Anti-CD3:anti-IL-2 receptor bispecific monoclonal antibody. Targeting of activated T cells in vitroJ A MacLean, Z Su, Y Guo, et al.Pageof 38